功能性便秘患者体征症状的身体和心理相关性:一个横截面研究
Zhifeng Zhao1, Bin Bai1, Shiqi Wang1
1State Key Laboratory of Cancer Biology & National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Air Force Medical University, No.127, West Changle Road, 710032, Xi'an, Shaanxi Province, People's Republic of China.
BMC psychiatry
|February 16, 2024
概括
功能性便秘 (FC) 患者体征症状经历更严重的便秘,焦虑和抑郁. 解决体质症状严重程度 (SSS) 对于有效的FC诊断和治疗至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 精神病体医学是一种精神病体医学.
- 临床心理学 临床心理学
背景情况:
- 功能性便秘 (FC) 受心理健康的影响,但FC患者体征症状的特征尚未研究.
- 身体症状显著影响功能性便秘的体验和严重程度.
研究的目的:
- 调查功能性便秘 (FC) 患者的临床特征,这些患者有体质症状 (SOM).
- 确定FC患者体质症状严重程度 (SSS) 的预测因素.
- 探索FC中压力因素和SSS之间的关系.
主要方法:
- 具有和没有显着体征症状的FC患者之间的临床参数比较 (SOM+与SOM-).
- 利用对体症状 (PHQ-15),抑郁 (PHQ-9),焦虑 (GAD-7) 和便秘 (KESS) 的验证问卷.
- 进行了相关性和后勤回归分析,以确定SSS的预测因素和与压力因素的关联.
主要成果:
- 与SOM-患者相比,患有体质症状 (SOM+) 的FC患者在性别,压力,睡眠,情绪,生活质量和解剖因素方面表现出显著的差异.
- 抑郁症 (PHQ-9),焦虑症 (GAD-7) 和便秘严重程度 (KESS) 是体质症状严重程度 (SSS) 的独立预测因素.
- 升高的SSS与与夫妇,父母和工作有关的压力因素有显著的关联.
结论:
- 功能性便秘患者身体症状呈现出更大的便秘,焦虑和抑郁.
- 身体症状评估对于功能性便秘的全面诊断和治疗计划至关重要.
- 心理困扰,体征症状和压力因素之间的相互作用凸显了在FC管理中需要综合护理方法的需要.
相关概念视频
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
160
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
160
Assessment of the Rectum and Anus
220
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
220
Irritable Bowel Syndrome I: Introduction
274
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
274
Assessment of the Gastrointestinal System II: Health Perception Pattern
115
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
115
Drugs for Treatment of Constipation-Predominant IBS
164
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
164
Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450


